any of these factors can drive this stock to $90+ range in short term
Bottom line, VRX is getting undervalued by "holding company discount". There is no reason for VRX to put them under one umbrella. Bausch + Lomb is a multi billion dollar company by itself.
New CEO/board of directors/Ackman should consider spinning off B + L as a separate entity like how ABT did it with AbbVie - their combined market cap went up 50%+ just because of spin off.